Please login to the form below

Not currently logged in
Email:
Password:

InterbrandHealth

This page shows the latest InterbrandHealth news and features for those working in and with pharma, biotech and healthcare.

Building brand strength – Part 4

Building brand strength – Part 4

We hope you enjoyed finding out about InterbrandHealth's 10 components of brand strength. ... associate director, analytics team, InterbrandHealth.

Latest news

  • Brand DNA: decoding the next generation Brand DNA: decoding the next generation

    Yet interestingly, in the analysis of the Iconic Brands Survey analysis InterbrandHealth's Karen Choueiri talks specifically about one of the key attributes associated with brand strength that is rising in

  • Iconic Brands Survey: The results Iconic Brands Survey: The results

    You may also find InterbrandHealth's white paper, Vital Times: The Changing Role of Brand within the Health &Life Sciences Industry, of interest. ... associate director, analytics team, InterbrandHealth.

  • Building brand strength – Part 3 Building brand strength – Part 3

    associate director, analytics team, InterbrandHealth.

  • Building brand strength – Part 2 Building brand strength – Part 2

    The Author. Melody Wolff is marketing manager at InterbrandHealth. ... Marketing Manager at InterbrandHealth.

  • Building brand strength – Part 1 Building brand strength – Part 1

    For more information on this topic and how InterbrandHealth can help build your brand please contact us for a chatYou may also find our  white paper, Vital Times: The Changing Role ... associate director, analytics team, InterbrandHealth.

More from news
Approximately 6 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics